Literature DB >> 8047298

cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors.

J K Harrison1, C M Barber, K R Lynch.   

Abstract

A series of cDNAs and a genomic clone (named RBS11) were isolated, from a variety of rat brainstem, pituitary and/or spinal cord cDNA libraries and a genomic library by low-stringency hybridization screening with a rat angiotensin receptor cDNA. The RBS11 protein, as conceptualized from these DNAs, is a novel member of the rhodopsin family of the G-protein-coupled receptor (GCR) superfamily. Comparison of RBS11 to other members of the GCR superfamily suggests that the RBS11 protein might be a receptor for a peptide ligand in the chemokine family. The RBS11 protein sequence is unusual in that it is without N-linked glycosylation consensus sequences in the putative exofacial regions. Northern analysis indicates that the mRNA for RBS11 accumulates widely and unevenly in the adult rat, with the mRNA being most prominent in extracts of spinal cord, brain, kidney, gut, uterus and testes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8047298     DOI: 10.1016/0304-3940(94)90362-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Role of chemokines in inflammation and immunoregulation.

Authors:  L Feng
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

3.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia.

Authors:  J K Harrison; Y Jiang; S Chen; Y Xia; D Maciejewski; R K McNamara; W J Streit; M N Salafranca; S Adhikari; D A Thompson; P Botti; K B Bacon; L Feng
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  Upregulation of chemokine receptor gene expression in brains of Borna disease virus (BDV)-infected rats in the absence and presence of inflammation.

Authors:  Mathias Rauer; Axel Pagenstecher; Jürgen Schulte-Mönting; Christian Sauder
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

5.  Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour.

Authors:  Fiona E Holmes; Nighat Arnott; Penny Vanderplank; Niall C H Kerr; Erin E Longbrake; Philip G Popovich; Toshio Imai; Christophe Combadière; Philip M Murphy; David Wynick
Journal:  J Neurochem       Date:  2008-04-12       Impact factor: 5.372

Review 6.  Learning and memory ... and the immune system.

Authors:  Ioana Marin; Jonathan Kipnis
Journal:  Learn Mem       Date:  2013-09-19       Impact factor: 2.460

Review 7.  Fractalkine/CX3CR1 signaling during neuropathic pain.

Authors:  Anna K Clark; Marzia Malcangio
Journal:  Front Cell Neurosci       Date:  2014-05-07       Impact factor: 5.505

Review 8.  The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain.

Authors:  Karli Montague; Marzia Malcangio
Journal:  J Neurochem       Date:  2017-02-24       Impact factor: 5.372

Review 9.  Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.

Authors:  Łukasz A Poniatowski; Piotr Wojdasiewicz; Maciej Krawczyk; Dariusz Szukiewicz; Robert Gasik; Łukasz Kubaszewski; Iwona Kurkowska-Jastrzębska
Journal:  Mol Neurobiol       Date:  2016-03-01       Impact factor: 5.590

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.